ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License
ScripPotentially competing with gene therapy in the unmet medical need of retinitis pigmentosa (RP), Aldeyra Therapeutics, Inc. reported statistical significance across multiple measures in a small Phase